|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Menstrual dysfunction following use of oral contraceptives. |
| Obstetrics and Gynecology 35(5): 734-739. May 1970. |
| An evaluation of 13 patients with menstrual dysfunction following discontinuation of oral contraceptives is presented. |
| All had normal ovulatory cycles of 26-34 days before beginning oral contraceptive medication. The duration of |
| therapy was 3-42 months with 14 months the mean. Relationship between occurrence of menstrual dysfunction and |
| duration of therapy or type of agent administered was not noted. 9 were classified as amenorrheic (6 months or more |
| of secondary amenorrhea) and their condition lasted from 6 to 36 months. Cervical mucus from 6 demonstrated a 3 |
| to 4+ fern phenomena, indicating significant endogenous estrogen production. Gynecologic endocrine status was |
| evaluated by basal body temperature, endometrial biopsy, and cervical mucus arborization. Total gonadotropins were |
| measured in those demonstrating poor or absent fern phenomenon. Adrenal and thyroid functions were measured by |
| 17-ketosteroid and 17-hydroxysteroid excretion and PBI respectively. Patients were screened for pituitary tumors by |
| X-ray and visual examinations. Clomiphene (Clomid) was administered to 6 patients in 5 day courses of 50 or 100 |
| mg per day. Of these 4 responded with ovulatory cycles. One became pregnant. 2 patients not responding to several |
| such courses, were given human menopausal gonadotropin (HMG Pregova) in doses of 140 I.U. a day until cervical |
| mucus demonstrated 4+ fern phenomenon. Human chorionic gonadotropin (HCG) was then given in a single dose of |
| 5000 I.U. One responded to this treatment and became pregnant. 3 were not treated because they did not desire |
| conception or ovulation induction. The 4 patients who were amenorrheic for less than 6 months were considered |
| oligomenorrheic. 2 responded to clomiphene but the pattern of prolonged follicular phase has recurred in both. |
| Their menstrual dysfunction is thought to be due to delayed recovery from suppression of some hypothalamic- |
| pituitary mechanisms involved in normal gonadotropin regulation. Gonadtropin therapy is the only effective method of |
| ovulation induction in those patients who fail to respond to clomiphene. (PubHealth.info Document ID: CONT8T |
| PubHealth.info NOTE: The author(s) of this article titled, "Menstrual dysfunction following use of oral |
| contraceptives.", is(are) Homesley HD; Goss DA. The source of this article is "Obstetrics and Gynecology 35(5): |
| 734-739. May 1970.". This article was published in 1970 in English language(s). (PubHealth.info® Document ID: |
| CONT8T 4565-06. All rights reserved with PubHealth.info) PIN: 39565 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |